Related Experiment Video
Updated: Feb 21, 2026

Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy
Published on: October 19, 2018
Mutational landscape of RNA-binding proteins in human cancers
Yaseswini Neelamraju1, Abel Gonzalez-Perez2, Poornima Bhat-Nakshatri3
1a Department of Bio Health Informatics, School of Informatics and Computing , Indiana University Purdue University , Indianapolis , Indiana , USA.
Abstract:
RNA Binding Proteins (RBPs) are a class of post-transcriptional regulatory molecules which are increasingly documented to be dysfunctional in cancer genomes. However, our current understanding of these alterations is limited. Here, we delineate the mutational landscape of ∼1300 RBPs in ∼6000 cancer genomes. Our analysis revealed that RBPs have an average of ∼3 mutations per Mb across 26 cancer types. We identified 281 RBPs to be enriched for mutations (GEMs) in at least one cancer type. GEM RBPs were found to undergo frequent frameshift and inframe deletions as well as missense, nonsense and silent mutations when compared to those that are not enriched for mutations. Functional analysis of these RBPs revealed the enrichment of pathways associated with apoptosis, splicing and translation. Using the OncodriveFM framework, we also identified more than 200 candidate driver RBPs that were found to accumulate functionally impactful mutations in at least one cancer. Expression levels of 15% of these driver RBPs exhibited significant difference, when transcriptome groups with and without deleterious mutations were compared. Functional interaction network of the driver RBPs revealed the enrichment of spliceosomal machinery, suggesting a plausible mechanism for tumorogenesis while network analysis of the protein interactions between RBPs unambiguously revealed the higher degree, betweenness and closeness centrality for driver RBPs compared to non-drivers. Analysis to reveal cancer-specific Ribonucleoprotein (RNP) mutational hotspots showed extensive rewiring even among common drivers between cancer types. Knockdown experiments on pan-cancer drivers such as SF3B1 and PRPF8 in breast cancer cell lines, revealed cancer subtype specific functions like selective stem cell features, indicating a plausible means for RBPs to mediate cancer-specific phenotypes. Hence, this study would form a foundation to uncover the contribution of the mutational spectrum of RBPs in dysregulating the post-transcriptional regulatory networks in different cancer types.
Insights
This study maps mutations in RNA Binding Proteins (RBPs) across thousands of cancer genomes, identifying key RBPs driving cancer and revealing their role in post-transcriptional regulation and tumor development.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Post-transcriptional Regulation
Background:
- RNA Binding Proteins (RBPs) are crucial for post-transcriptional gene regulation.
- Dysfunctional RBPs are increasingly implicated in cancer genomes, but their specific roles are not fully understood.
- A comprehensive analysis of RBP mutations in cancer is needed to elucidate their contribution to tumorigenesis.
Purpose of the Study:
- To delineate the mutational landscape of approximately 1300 RBPs across nearly 6000 cancer genomes.
- To identify cancer-specific RBP mutation hotspots and driver RBPs.
- To investigate the functional impact of RBP mutations on cancer pathways and phenotypes.
Main Methods:
- Analysis of mutational data from ∼6000 cancer genomes focusing on ∼1300 RBPs.
- Identification of mutationally enriched RBPs (GEMs) and candidate driver RBPs using the OncodriveFM framework.
- Functional enrichment analysis, network analysis, and gene knockdown experiments in cancer cell lines.
Main Results:
- Identified 281 RBPs enriched for mutations (GEMs) across 26 cancer types, with frequent frameshift, deletion, and missense mutations.
- Discovered over 200 candidate driver RBPs with functionally impactful mutations, affecting pathways like apoptosis, splicing, and translation.
- Network analysis revealed altered protein interaction networks and cancer-specific RNP mutational hotspots; knockdown experiments showed RBPs mediate cancer-specific stem cell features.
Conclusions:
- Mutations in RBPs are widespread in cancer and significantly impact post-transcriptional regulatory networks.
- Specific driver RBPs and their mutational patterns offer potential therapeutic targets and insights into cancer heterogeneity.
- This study provides a foundational understanding of the RBP mutational spectrum in cancer, paving the way for further investigation into their oncogenic roles.
Related Concept Videos
The Ras Gene
Ras is a...
RNA Stability
lncRNA - Long Non-coding RNAs
The Nucleolus
RNA Splicing
Leaky Scanning

